- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02156167
Clinical Assessment of the External Sound Processor Worn by Patients Implanted With Codacs
Clinical Validation of the Nucleus® CP810 Sound Processor for the Codacs™ System
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Niedersachsen
-
Hannover, Niedersachsen, Germany, 30625
- Hannover Medical School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects implanted with a Cochlear C-DACS investigational device
Exclusion Criteria:
- Participation in another medical device study
- Unwillingness or inability of the subject to comply with the study requirements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CP810 and Codacs™Test System
Nucleus® CP810 Sound Processor for the Codacs™ system (CE marked) and Codacs™ Test System (CE marked)
|
Nucleus® CP810 Sound Processor for the Codacs™ system (CE marked) and Codacs™ Test System (CE marked)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aided Speech Reception Threshold (SRT) in Noise Measured by Signal to Noise Ratio for 50% Correct Scores With the Oldenburger Sentence Test
Time Frame: 3 months after initial upgraded fitting
|
The Oldenburger Sentence test is an adaptive speech in noise test with a fixed noise level of typically 65 decibel (dB) sound pressure level (SPL) and a varying speech level, depending on how many words in a sentence were repeated correctly by the subject. The outcome of this test is the signal-to-noise ratio (SNR) at which 50% of words in the sentence list were correctly repeated by the subject. The SRT in noise with the Freedom sound processor at the initial study visit was compared to the SRT in noise with the CP810 at the 3 months follow-up at different measurement conditions. Speech and noise coming from the front (S0N0)- Speech coming from the front and noise coming from the implanted side (S0N90)- Everyday program (E): omnidirectional microphone- Noise program (N): directional microphone- Freedom Sound Processor (Freedom)- CP810 Sound Processor (CP810). |
3 months after initial upgraded fitting
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ernst von Wallenberg, PhD, Cochlear
Publications and helpful links
General Publications
- Lenarz T, Zwartenkot JW, Stieger C, Schwab B, Mylanus EA, Caversaccio M, Kompis M, Snik AF, D'hondt C, Mojallal H. Multicenter study with a direct acoustic cochlear implant. Otol Neurotol. 2013 Sep;34(7):1215-25. doi: 10.1097/MAO.0b013e318298aa76.
- Lenarz T, Verhaert N, Desloovere C, Desmet J, D'hondt C, Gonzalez JC, Kludt E, Macias AR, Skarzynski H, Van de Heyning P, Vyncke C, Wasowski A. A comparative study on speech in noise understanding with a direct acoustic cochlear implant in subjects with severe to profound mixed hearing loss. Audiol Neurootol. 2014;19(3):164-74. doi: 10.1159/000358004. Epub 2014 Feb 18.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEL5441
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe to Profound Mixed Hearing Loss
-
Novartis PharmaceuticalsCompletedUnilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing LossUnited States
-
Advanced Bionics AGNot yet recruitingHearing Loss, Sensorineural | Severe-to-profound Hearing LossBelgium, United Kingdom, France, Germany, Italy, Poland
-
Imam Abdulrahman Bin Faisal UniversityCompletedSevere to Profound Sensorineural Hearing Loss | Undergoing Cochlear Implant SurgerySaudi Arabia
-
Advanced Bionics AGCompletedSevere-to-profound Hearing LossNetherlands
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere to Profound Hearing LossFrance
-
University Hospital, AntwerpCochlearRecruitingHearing Loss, Unilateral | Cochlear Implants | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, Bilateral | Hearing Loss, Sensorineural, ProfoundBelgium
-
Advanced BionicsCompletedSevere to Profound Hearing Loss | in Adult Users of Advanced Bionics HiResolution™ Bionic Ear SystemUnited States
-
Cambridge University Hospitals NHS Foundation TrustAdvanced Bionics AGCompletedHearing Loss, Bilateral | Cochlear Implant | Hearing Loss, Cochlear | Severe-Profound Hearing LossUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Värmland County Council, SwedenEnrolling by invitationVestibular Disorder | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, ProfoundSweden
Clinical Trials on CP810 and Codacs™ system test
-
Assuta Hospital SystemsBSP Biological Signal Processing Ltd.Unknown
-
Medtronic DiabetesRecruitingType 2 Diabetes Treated With InsulinUnited States
-
Centro Studi Internazionali, ItalyVivaChek Laboratories, Inc.UnknownCoronavirus InfectionsItaly
-
Genomic Health®, Inc.Registrat-MapiCompletedBreast CancerFrance
-
University Hospital, Clermont-FerrandMr. Thierry PAPER - Biosynex CompanyUnknownBiomarkers | Predictive Value of Tests | Preterm Labor | Preterm Delivery | Immunochromatographic AssayFrance
-
Medtronic CardiovascularActive, not recruitingSymptomatic Aortic StenosisCanada, United States, Sweden, Israel, Germany, Belgium, United Kingdom, Australia, Italy, Ireland, France, Spain
-
PATHCentro de Pesquisa em Medicina Tropical de RondoniaRecruiting
-
Innovative MedicalCompletedVision CorrectionUnited States
-
Stryker Trauma GmbHTerminatedNeuropathy | Charcot; Disease (Etiology)United States